[Effect of heterologous antilymphocyte serum on experimental allergic encephalomyelitis].
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001772:Blood Cell Count; D001773:Blood Cells / Q000276:immunology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D005620:Freund's Adjuvant; D006168:Guinea Pigs; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008197:Lymph Node Excision; D008297:Male; D010243:Paralysis / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D013116:Spinal Cord; D014020:Tissue Extracts
D000906:Antibodies; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D014020:Tissue Extracts; D005620:Freund's Adjuvant
Wirkung eines heterologen Antilymphocytenserums auf die experimentelle allergische Encephalomyelitis.